Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Orlistat over the counter.

× No keyword cloud information.

9 in total

1. Diet, nutrition and the prevention of chronic diseases.

Authors:
Journal: World Health Organ Tech Rep Ser Date: 2003

Review 2. A review of long-term studies evaluating the efficacy of weight loss in ameliorating disorders associated with obesity.

Authors: F X Pi-Sunyer
Journal: Clin Ther Date: 1996 Nov-Dec Impact factor: 3.393

3. Obesity: preventing and managing the global epidemic. Report of a WHO consultation.

Authors:
Journal: World Health Organ Tech Rep Ser Date: 2000

4. The effect of orlistat-induced weight loss, without concomitant hypocaloric diet, on cardiovascular risk factors and insulin sensitivity in young obese Chinese subjects with or without type 2 diabetes.

Authors: Peter C Y Tong; Zoe S K Lee; Man-Mei Sea; Chun-Chung Chow; Gary T C Ko; Wing-Bun Chan; Wing-Yee So; Ronald C W Ma; Risa Ozaki; Jean Woo; Clive S Cockram; Juliana C N Chan
Journal: Arch Intern Med Date: 2002-11-25

5. Weight loss, weight maintenance, and improved cardiovascular risk factors after 2 years treatment with orlistat for obesity. European Orlistat Obesity Study Group.

Authors: S Rössner; L Sjöström; R Noack; A E Meinders; G Noseda
Journal: Obes Res Date: 2000-01

Review 6. Pharmacotherapy for obesity.

Authors: Lisa L Ioannides-Demos; Joseph Proietto; John J McNeil
Journal: Drugs Date: 2005 Impact factor: 9.546

7. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial.

Authors: T A Wadden; R I Berkowitz; D B Sarwer; R Prus-Wisniewski; C Steinberg
Journal: Arch Intern Med Date: 2001-01-22

8. Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

Authors: Diana Rucker; Raj Padwal; Stephanie K Li; Cintia Curioni; David C W Lau
Journal: BMJ Date: 2007-11-15

9. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

Authors: Jarl S Torgerson; Jonathan Hauptman; Mark N Boldrin; Lars Sjöström
Journal: Diabetes Care Date: 2004-01 Impact factor: 19.112

9 in total

3 in total

Orlistat over the counter.